By GINA KOLATA
A study of so-called PCSK9 inhibitors showed they can reduce the size of plaques in arteries that may cause heart attacks, a signal that they will show benefit in reducing heart attack risk.
Published: November 14, 2016 at 07:00PM
from NYT Health http://ift.tt/2gcPQO0
via IFTTT
from WordPress http://ift.tt/2fCPJqJ
via IFTTT
No comments:
Post a Comment